Načítá se...
Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women
INTRODUCTION: In settings where HIV is prevalent in heterosexual population, pregnancy and postpartum breastfeeding periods can be associated with substantial HIV acquisition risk. Pre-exposure prophylaxis (PrEP) with daily oral tenofovir disoproxil fumarate (TDF)/emtricitabine is an attractive HIV...
Uloženo v:
| Vydáno v: | Expert Opin Drug Saf |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581312/ https://ncbi.nlm.nih.gov/pubmed/28571500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1338271 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|